Call for members for an AAPM-EFOMP joint Task Group on "Invasive Cardiovascular X-ray Imaging"
Publication Date: Aug 22nd, 2022 18:06, Category: EFOMP Announcements
EFOMP hereby announces a new AAPM-EFOMP joint Task Group (TG) entitled “Invasive Cardiovascular X-ray Imaging”.
The Vice chair of the TG to represent EFOMP is Prof. Hilde Bosmans (BE).
X-ray angiography systems are used to diagnose and treat cardiovascular (CV) disease in adult and pediatric patients. Disease conditions commonly encountered in the invasive CV practice include arrhythmia, atrial fibrillation, chronic and acute coronary artery stenosis, and adult and pediatric structural heart disease. When imaging the vessels and devices within and near the heart, cardiac motion and rapid blood flow contribute to unique X-ray imaging conditions. Further, cardiovascular disease is treated with a variety of devices ranging in size from small to large compared to the spatial resolution properties of the X-ray systems.
The purpose of this TG is to generate a Report describing imaging conditions unique to diagnosis and treatment of cardiovascular disease; technical considerations for X-ray angiography and fluoroscopy imaging; and recommendations to optimize relationship between image quality and patient radiation dose.
This TG will respect the work of TG 272 - Comprehensive Acceptance Testing and Evaluation for Fluoroscopy Imaging Systems. The TG will actively seek membership by AAPM members and by extra- AAPM professional and manufacturing organizations including but not necessarily limited to European Federation of Organizations for Medical Physics (EFOMP), Canadian Organization of Medical Physicists (COMP), U.S. Food and Drug Administration (FDA) and Medical Imaging and Technical Alliance (MITA).
Members of the TG: should
- Know the European situation in a wider group of US and Canada
- Demonstrate interest in invasive CV imaging
- Altogether cover the four major vendors (Cannon, GE, Philips, Siemens)
- Represent a broad range of prior TG experience
- Have time to actively work on TG initiatives
- Adult and pediatric imaging
- Embrace the AAPM Diversity Statement
The TG will:
- Introduce disease conditions diagnosed and treated in invasive CV laboratories.
- Describe X-ray angiography and fluoroscopy imaging conditions unique to CV disease.
- Present technical considerations for X-ray fluoroscopy and angiography including X-ray control and generation, scatter rejection, image processing, and display.
- Recommend X-ray system performance tests specific to CV imaging (if not already included in TG 272 Report).
- Recommend strategies to optimize the relationship between image quality and patient radiation dose.
- Describe special considerations for imaging pediatric patients.
EFOMP National Member Organisations members interested to participate in this joint TG please send your CV to Hilde Bosmans at email@example.com